MAJOR DRUG POLICY POINTS – October 10, 2001
 
 By Robert S. Weiner, President, Robert Weiner Associates Public Affairs and Issue Strategies; former Director of Public Affairs, White House National Drug Policy Office ADDITIONAL CONTROVERSIES: